Department of Clinical and Molecular Medicine, School of Medicine and Psychology, Sapienza University of Rome, 00189 Rome, Italy.
IRCCS Neuromed, 86077 Pozzilli (Isernia), Italy.
Int J Mol Sci. 2019 Aug 16;20(16):3991. doi: 10.3390/ijms20163991.
The natriuretic peptides (NPs) family includes a class of hormones and their receptors needed for the physiological control of cardiovascular functions. The discovery of NPs provided a fundamental contribution into our understanding of the physiological regulation of blood pressure, and of heart and kidney functions. NPs have also been implicated in the pathogenesis of several cardiovascular diseases (CVDs), including hypertension, atherosclerosis, heart failure, and stroke. A fine comprehension of the molecular mechanisms dependent from NPs and underlying the promotion of cardiovascular damage has contributed to improve our understanding of the molecular basis of all major CVDs. Finally, the opportunity to target NPs in order to develop new therapeutic tools for a better treatment of CVDs has been developed over the years. The current Special Issue of the Journal covers all major aspects of the molecular implications of NPs in physiology and pathology of the cardiovascular system, including NP-based therapeutic approaches.
利钠肽(NPs)家族包括一类激素及其受体,这些激素及其受体对于心血管功能的生理控制是必需的。NPs 的发现为我们理解血压、心脏和肾脏功能的生理调节做出了重要贡献。NPs 也与几种心血管疾病(CVDs)的发病机制有关,包括高血压、动脉粥样硬化、心力衰竭和中风。对依赖 NPs 的分子机制以及促进心血管损伤的基础的精细理解有助于我们更好地理解所有主要 CVDs 的分子基础。最后,多年来,人们一直致力于针对 NPs 开发新的治疗工具,以更好地治疗 CVDs。本期特刊涵盖了 NPs 在心血管系统生理学和病理学中的分子影响的所有主要方面,包括基于 NPs 的治疗方法。